Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain
Condition: Endometriosis · Sponsor: Kissei Pharmaceutical Co., Ltd.
About this study
The primary objective of this extension study is to assess the maintenance of efficacy of linzagolix administered orally once daily for up to an additional 6 months (for up to 12 months of treatment in total) in women who have already completed 6 months of linzagolix treatment at a dose of 75 mg alone or of 200 mg in combination with ABT (E2 1 mg / NETA 0.5 mg), in the management of moderate to severe endometriosis-associated pain (EAP) in women with surgically confirmed endometriosis.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (25)
| Applied Res Center of Ar / Id # 735 | Little Rock, Arkansas, United States | — |
| Futura Research, Inc. / ID # 781 | Norwalk, California, United States | — |
| Adv Womens Health Institute / ID # 761 | Greenwood Village, Colorado, United States | — |
| Red Rocks OB/GYN / ID # 732 | Lakewood, Colorado, United States | — |
| Dr. David I. Lubetkin, LLC / ID # 703 | Boca Raton, Florida, United States | — |
| Coral Way Research / ID # 799 | Miami, Florida, United States | — |
| La Salud Research Clinic, Inc. / ID # 824 | Miami, Florida, United States | — |
| A Premier Medical Research of Florida, LLC / ID # 752 | Orange City, Florida, United States | — |
| Clinical Associates of Orlando, LLC / ID # 779 | Orlando, Florida, United States | — |
| Providea Health Partners LLC / ID # 734 | Evergreen Park, Illinois, United States | — |
| Onyx Clinical Research / ID # 793 | Flint, Michigan, United States | — |
| Valley OBGYN / ID # 704 | Saginaw, Michigan, United States | — |
+ 13 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04372121